<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00448422</url>
  </required_header>
  <id_info>
    <org_study_id>OPT-099-002</org_study_id>
    <nct_id>NCT00448422</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers</brief_title>
  <official_title>A Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Acute Gastroenteritis in Adult Travelers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optimer Pharmaceuticals LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Optimer Pharmaceuticals LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pivotal Phase III study is to investigate the safety and efficacy of
      prulifloxacin versus placebo in the treatment of patients with acute bacterial
      gastroenteritis (traveler's diarrhea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This double-blind trial will compare the safety and efficacy of prulifloxacin versus placebo
      in adult travelers with acute gastroenteritis characterized by diarrhea with one or more of
      the following signs or symptoms: nausea, vomiting, abdominal pain or cramping, fecal urgency,
      moderate to severe other gastrointestinal-related symptoms, or tenesmus of &lt;72 hours
      duration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Last Unformed Stool (TLUS)</measure>
    <time_frame>End of Therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiologic eradication rates</measure>
    <time_frame>End of therapy/study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical cure based on relief of signs and symptoms</measure>
    <time_frame>End of therapy/study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">268</enrollment>
  <condition>Acute Bacterial Gastroenteritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prulifloxacin</intervention_name>
    <description>Tablet</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of acute bacterial gastroenteritis

          -  Traveler from an industrialized country

          -  Capable of giving Informed Consent

        Exclusion Criteria:

          -  Fever (&gt;100.3 degrees)

          -  Pregnant or Breast Feeding or Not using adequate birth control

          -  Known or Suspected (co-)Infection with non-bacterial pathogen

          -  Symptoms of acute gastroenteritis of &gt;72 hours duration

          -  Bloody Diarrhea

          -  Concomitant antibacterial with activity against enteric bacterial pathogens

          -  History of IBD

          -  Unable/Unwilling to comply with study protocol

          -  Greater than two doses of an antidiarrheal medication within 24 hours

          -  &gt; 2 doses of anti-diarrheal medication within 24 hours

          -  Antimicrobial treatment within 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Steffen, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Goa Medical College</name>
      <address>
        <city>Bambolim</city>
        <state>Goa</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2007</study_first_submitted>
  <study_first_submitted_qc>March 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2007</study_first_posted>
  <disposition_first_submitted>August 27, 2010</disposition_first_submitted>
  <disposition_first_submitted_qc>August 27, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">August 31, 2010</disposition_first_posted>
  <last_update_submitted>September 22, 2010</last_update_submitted>
  <last_update_submitted_qc>September 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Y.K. Shue</name_title>
    <organization>Optimer Pharmaceuticals</organization>
  </responsible_party>
  <keyword>Traveler's</keyword>
  <keyword>Diarrhea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroenteritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prulifloxacin</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

